A carregar...
Eligibility Criteria and Endpoints in Metastatic Renal Cell Carcinoma Trials
OBJECTIVES: Treatments for metastatic renal cell carcinoma (mRCC) are often compared across trials, but trial eligibility criteria and endpoints differ. In an effort to better align trials, the Definition for the Assessment of Time to event Endpoints in CANcer trials (DATECAN) project published reco...
Na minha lista:
| Publicado no: | Am J Clin Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7515769/ https://ncbi.nlm.nih.gov/pubmed/32398404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0000000000000705 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|